.After antibody-drug conjugate (ADC) specialist Seagen was marketed to Pfizer last year for an immen...
.On the heels of a stage 3 win that stopped working to excite capitalists, Ironwood Pharmaceuticals ...
.Don't cease Monte Rosa Therapeutics right now. The Boston-based biotech is actually enjoying after ...
.Invite to recently's Chutes & Ladders, our summary of significant leadership hirings, firings as...
.Celebrating his company's upsized going public (IPO), Septerna CEO Jeffrey Finer rang the position ...
.AbbVie has actually come back to the resource of its antipsychotic giant Vraylar looking for one mo...
.GenSight Biologics is full weeks off of lacking money. Again. The biotech merely has adequate cash ...
.Monopar Therapies is recouping a medicine coming from the dump of AstraZeneca's uncommon disease pi...
.Along with new information out on Arcus Biosciences' speculative HIF-2a inhibitor, one group of exp...
.After developing a genetics therapy alliance with Dyno Therapies in 2020, Roche is back for even mo...